Dr Lal Pathlabs Reports Record Sales and Profit Growth Amid Evaluation Decline in June 2025
Dr Lal Pathlabs has reported its financial results for the quarter ending June 2025, achieving net sales of Rs 669.80 crore, the highest in five quarters. Profit after tax reached Rs 132.40 crore, reflecting a year-on-year growth of 24.4%. Non-operating income also peaked at Rs 28.10 crore.
Dr Lal Pathlabs, a prominent player in the healthcare services industry, has recently reported its financial results for the quarter ending June 2025. The company achieved net sales of Rs 669.80 crore, marking the highest figure recorded in the last five quarters. This positive sales trend reflects a robust performance in the near term.Additionally, the profit after tax (PAT) for the quarter stood at Rs 132.40 crore, showcasing a year-on-year growth of 24.4%. This growth indicates a favorable trajectory for the company's profitability in the near term.
However, it is noteworthy that the company has experienced an adjustment in its evaluation, with the score reflecting a decline from 14 to 11 over the past three months. This revision highlights the complexities within the financial landscape of Dr Lal Pathlabs.
On another note, the non-operating income reached Rs 28.10 crore, the highest in the last five quarters. While this increase is notable, it raises questions about the sustainability of income derived from non-business activities.
For more insights and updates on Dr Lal Pathlabs, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
